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SpainABSTRACT Nanomechanical analysis of proteins by single-molecule force spectroscopy based on atomic force microscopy is
increasingly being used to investigate the inner workings of mechanical proteins and substrate proteins of unfoldasemachines as
well as to gain new insight into the process of protein folding. However, such studies are hindered by a number of technical prob-
lems, including the noise of the proximal region, ambiguous single-molecule identification, as well as difficulties in protein expres-
sion/folding and full-length purification. To overcome these major drawbacks in protein nanomechanics, we designed a family of
cloning/expression vectors, termed pFS (plasmid for force spectroscopy), that essentially has an unstructured region to surmount
the noisy proximal region, a homomeric polyproteinmarker, a carrier tomechanically protect the protein of interest (only the pFS-2
version) that also acts as a reporter, and two purification tags. pFS-2 enables the unambiguous analysis of proteins with low
mechanical stability or/and complex force spectra, such as the increasingly abundant class of intrinsically disordered proteins,
which are hard to characterize by traditional bulk techniques and have important biological and clinical implications. The advan-
tages, applications, and potential of this ready-to-go system are illustrated through the analysis of representative proteins.INTRODUCTIONThe study of protein nanomechanics typically relies on
stretching the protein of interest using single-molecule force
spectroscopy (SMFS) techniques to measure its mechanical
resistance. A commonly used technique is atomic force
microscopy (AFM). In this versatile technique, a protein
that is attached to a substrate and the tip of a cantilever
(the sensor) is stretched by a piezoelectric device and the
forces of resistance are measured (1).
Investigators have developed several approaches to
unambiguously identify and select single-molecule record-
ings. The first such approach was based on the use of homo-
polyproteins (identical repeats of the protein or protein
region under study), which enabled researchers to identify
single-molecule recordings as those carrying periodical
patterns, and to discard aperiodic patterns (1,2). According
to this strategy, the force-extension traces obtained with the
length-clamp mode of the atomic force microscope should
display a pattern of equally spaced peaks (the so-called
sawtooth pattern) in which each peak typically originates
from the unfolding of an individual (structured) protein.
Thus, the process of unfolding can usually be modeled as
a two-state (folded and unfolded) process (1). The height
of each force peak is used to calculate the mechanical
stability of the protein (Fu, defined as the average unfolding
force), and the distance between peaks is used to measure
the length of the protein region that is being unfolded
(hidden to the force) by calculating the increase in contour
length of the molecule (DLc, obtained after fitting the
force-extension recordings to the worm-like chain (WLC)Submitted July 28, 2011, and accepted for publication December 12, 2011.
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0006-3495/12/02/0682/9 $2.00equation of polymer elasticity) (3). From this last parameter,
we can easily calculate the number of amino acids contained
in the force-hidden region of the protein (applying the ratio
of 0.4 nm/amino acid (1,4)). These parameters depend on
the pulling geometry, which in proteins is usually the N-C
direction (the natural geometry of their peptide bonds).
In an alternative approach, the protein of interest is fused
to a known AFM-SMFS homopolyprotein marker (i.e.,
a fusion heteropolyprotein) that acts as both a useful internal
positive control of the technique and a single-molecule
reporter (5–7).
To avoid the tedious process of synthesizing identical
repeats of the protein of interest, a versatile cloning/
expression vector was later developed in which the protein
of interest is cloned as a fusion protein with a built-in poly-
protein marker, a series of I27 modules (an immunoglobulin
module from human cardiac titin, a model system in AFM-
SMFS (1)), that acts as a single-molecule marker (8). This
strategy allows the simple construction of heteropolypro-
teins such that the force peak(s) resulting from the unfolding
of the protein under study can usually be identified unam-
biguously in the force curves (Fig. 1). However, although
this system is very helpful, its use is limited by several draw-
backs depending on the mechanical properties of the protein
of interest.
More recently, a new approach based on the use of
single proteins flanked by long handles was reported (9).
This strategy was shown to be extremely useful in mechan-
ical folding studies (10), and it has the advantage of
validating the suitability of the polyprotein approach.
However, its utility for analyzing proteins whose mechan-
ical properties have not been previously characterized
remains to be demonstrated.doi: 10.1016/j.bpj.2011.12.019
FIGURE 1 Examples of AFM-SMFS recordings obtained using a stan-
dard heteropolyprotein approach. (a) In AFM-SMFS, it is usual to obtain
contaminated force-extension recordings. (b) In some cases, one may
obtain a longer-than-expected recording that may originate from oligomers
of the protein under study, and thus such recordings should be discarded
from the analyses. In this example, the protein is (I27)3-EC1,2-(I27)2, where
EC refers to C-cadherin extracellular domains (12). Although no more than
seven unfolding peaks are expected if the full-length polyprotein is picked
up, an extra I27 peak was obtained (arrow). (c and d) The proximal region
of the recording can often appear contaminated, hiding the unfolding peaks
of the protein of interest when its mechanical stability is lower than that of
the marker. These recordings were obtained using the same polyprotein as
in panel b, where the first unfolding peak that originated from an EC could
be masked by the contamination of the proximal region of the recording
(arrow in c). In such cases, the only way to increase the chance of getting
clean recordings is to lower the protein concentration (d). (e) For proteins
that are more mechanically stable than the marker (I27 in this figure),
this standard heteropolyprotein approach is adequate for unambiguous
single-molecule identification. The force peak of the protein of interest
will always appear after the force peaks of the protein marker in the
recording (arrow). In this case, a recording from (I27)3-c7A-(I27)2 is shown
(c7A comes from the seventh cohesin module from CipA scaffoldin of
Clostridium thermocellum) (13).
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described above, have been successfully applied to several
proteins. The presence of a simple sawtooth pattern is taken
as a fingerprint to identify the recordings that carry informa-
tion about the unfolding of individual molecules (Fig. 1). In
general, to maximize the number of good single-molecule
recordings, one needs to ensure that the concentration of
pure protein is not too high (0.2–0.5 mg/ml).
However, there are still several drawbacks that hamper
this approach. Regardless of the strategy used to identify
single-molecule recordings in AFM-SMFS, the proximal
(to substrate) region of the recordings (typically the first
50–75 nm) is often contaminated with what are collectively
called unspecific interactions (Fig. 1, a–c). These are unde-
fined patterns of force peaks that originate from many sour-
ces, including protein desorption (from either the substrate
or the cantilever tip), surface-denatured or aggregated pro-
teins, and multiple molecules in parallel, among otherunwanted events (1). Frequently, good recordings display
these unspecific interactions followed by a typical sawtooth
pattern that can be fitted to theWLC. However, if the protein
of interest has a lower mechanical stability than the marker,
its force resistance events may appear in this contaminated
region and be masked by this undefined pattern, followed
by the events of the marker (Fig. 1 c) (11,12). In this case,
the single criterion of observing a simple sawtooth pattern
carrying the flanking markers is not sufficiently stringent,
and it becomes a necessary but insufficient condition that
can lead to an erroneous selection of false-positive re-
cordings as real data (11). The only solution in these cases
is to lower the concentration of the sample until a clean
(featureless) proximal region is obtained (Fig. 1 d). After
examining many of these recordings, if the DLc is unique
(i.e., not complex or polymorphic), one can take this value
as an additional single-molecule fingerprint.
Conversely, when the mechanical stability of the protein
of interest is higher than that of the marker (typically the
I27 module (1,8)), its force peak will normally appear in
the recordings after those of the marker, and hence it will
not be affected by this problem (Fig. 1 e) (13).
Still, in any SMFS experiment that uses proteins,
aperiodic force-extension recordings are often obtained
even with very clean protein preparations (resulting from
an optimal purification) as a result of nonspecific interac-
tions. Furthermore, even if the polyprotein is kept in con-
ditions that prevent oligomerization in solution (usually
reducing conditions to avoid the formation of disulfide bonds
between cysteine residues, typically placed at one end of the
polyprotein for covalent attachment to gold substrates),
longer-than-expected (supernumerary) recordings are occa-
sionally obtained. These may result from either intermolec-
ular disulfide-bonding or intermolecular entanglement.
Moreover, as would be expected from sampling statistics,
recordings that are shorter than the expected length of the
full-length molecule (pulled from its termini) are commonly
obtained. This problem is aggravated if degraded species of
the polyprotein are present in the preparation.
To aid in the selection of data in AFM-SMFS, the
following general guidelines have been proposed: 1), the
proximal region should be clean to avoidmasking the protein
of interest; 2), the peak-to-peak distance (or distances, if
there are unfolding intermediates) should be reproducible
and close to the expected contour length of the force-hidden
region of the protein, but it should not display other interca-
lated peaks (whichmay originate frommore than one protein
attached to the tip); 3), the protein should not show more un-
folding peaks than those expected from the cloning strategy;
and 4), the total length of the unfolded protein should not be
longer than that expected from the length of the complete
polypeptide (14,15).
These criteria work reasonably well for most structured
proteins. However, if the protein of interest produces com-
plex or polymorphic AFM-SMFS spectra that include aBiophysical Journal 102(3) 682–690
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virtually impossible to distinguish the real data from
the proximal noise. In this case, as with some intrinsically
disordered proteins (IDPs; e.g., neurotoxic proteins (11)),
all of the aforementioned conditions, although necessary,
are insufficient.
To overcome these limitations, we developed a system we
call pFS (plasmid for force spectroscopy), which has several
advantages that make it an optimal strategy to produce
polyproteins for general use in AFM-SMFS (Fig. 2 a). This
system is based on the cassette (intercalary) strategy
described elsewhere (8), although the single-moleculeFIGURE 2 pFS-1 protein. (a) Schematic representation of the pFS-1
protein. The ubiquitin repeats are represented as gray boxes and termed
U, followed by the number of the repeat in the construct. The N2B fragment
is represented as a nonfolded polypeptide (curving line). This vector
contains two purification tags to optimize the purification of the full-length
form (His-tag at the N-terminus and Strep-tag at the C-terminus). At the
C-terminus there are also two cysteine residues for attachment to gold-
coated substrates (20). The vector contains eight restriction sites (BamHI,
XbaI, SalI, NotI, SpeI, BssHII, XhoI, and KpnI), facilitating the cloning
of the protein of interest (ideally performed with NotI, SpeI, BssHII, or
XhoI to make full use of the advantages of this vector). (b) Western blot
to monitor the induction of the expression of pFS-1 protein cloned into the
pRSETA vector (Stratagene) using the C41(DE3) E. coli strain (29). The
nominal molecular mass of the protein is 80 kDa according to ProtParam
(http://www.expasy.org/tools/protparam.html). An anti-Histag antibody
labels the N-terminus, and an anti-Strep-tag labels the C-terminus. NI, non-
induced; I, induced. (c) After two-step affinity purification (Ni2þ affinity and
Strep affinity), a single band is observed by CB staining and inWestern blots
probed with each antibody. (d) Typical force-extension recording of pFS-1.
The extension gained by the stretching of the N2B fragment (aperiodical
region of the retraction recording) serves as a spacer to avoid the usually
contaminated proximal region of the force-extension recordings. The ubiq-
uitin force peaks are shown in black.
Biophysical Journal 102(3) 682–690markers used are ubiquitin repeats instead of I27 modules.
Ubiquitin’s nanomechanical properties are well known
(9,10,16) and it has the additional advantage of behaving
like a chaperone, which in principle may prevent incorrect
folding (and possibly its subsequent aggregation) of the
protein of interest (17). The first member of this family of
vectors, termed pFS-1, contains a fragment of an IDP, the
N2B polypeptide of human cardiac titin, the featureless un-
folding pattern of which will appear in the proximal region
of the force-extension recording (18). This element acts as
a spacer, such that the observable force peaks (from both
the protein under study and the marker) will appear farther
away from this noisy region of the recordings (Figs. 1 and
2). Moreover, it contains an affinity purification tag at each
terminus of the protein (a His-tag and a Strep-tag), which,
in addition to increasing the versatility of the purification
process, allows the full-length form of the protein to be puri-
fied, thereby limiting the presence of degraded or truncated
species in the purified sample (Fig. 2, b and c). Furthermore,
as the N-terminus contains a His-tag, it can also be used for
Ni2þ-nitrilo triacetic acid (NTA) substrate attachment (19).
The C-terminus, which contains two cysteine residues, can
be used for covalent attachment to a gold substrate (20).
A variant of this vector, termed pFS-2 (Fig. 3), was
designed for the unequivocal single-molecule analysis
of proteins with low (12) or/and complex/polymorphic
mechanical stability (e.g., amyloidogenic IDPs (21) such
as neurotoxic proteins (22)). The possibility of unambigu-
ously analyzing the single-molecule mechanics of IDPs is
of particular relevance given that ~40% of eukaryotic
proteins possess at least one long disordered region (>50
residues), and it is difficult to characterize these proteins
by traditional bulk techniques (21). This vector is partic-
ularly useful for analyzing neurotoxic proteins, a subset
of IDPs that cause neurodegenerative diseases such as
Alzheimer’s or Parkinson’s (22). In this vector, we modified
a ubiquitin repeat that is present in pFS-1 to introduce a mul-
ticloning site (MCS) within a tolerant loop of the protein to
facilitate the cloning of the protein of interest in a mechani-
cally protected way. In this manner, the carrier ubiquitin
repeat unfolds mechanically before the protein of interest
(which is force-hidden within) is stretched, announcing
that the mechanical protection has been broken and the force
has access to the protected region and can stretch the protein
of interest (the mechanical features of which would appear
afterward in the recording). Peng and Li (23) recently re-
ported mechanical protection by domain insertion indepen-
dently using different proteins. We call this kind of approach
the carrier-guest strategy (Fig. 3 a). To effectively avoid the
contamination of the noisy proximal region of the AFM
recordings, pFS-2 combines the spacer (N2B fragment)
and a carrier (e.g., ubiquitin or else) into which the protein
of interest (the guest) can be inserted by means of regular
DNA cloning procedures (Fig. 3, b and e). Thus, pFS-2 is
particularly useful for mechanically polymorphic proteins.
FIGURE 4 Use of the carrier-guest strategy. (a) Typical force-extension
recording of the pFS-2þI27 protein carrying (in this order) the N2B region
and unfolding peaks from the ‘‘carrier’’ ubiquitin, three ubiquitin repeats,
and the I27. The unfolding peak of the carrier ubiquitin repeat must always
precede the unfolding peak of the guest I27 module (23). This carrier ubiq-
uitin shows a larger DLc due to the inclusion in its fold of the MCS and the
folded I27. The inset shows a representation of the ubiquitin carrier with
the I27 module grafted inside (top; PDB code 1TIT) as visualized by
VMD 1.8.6 (48). (b) The DLc analysis of the elements in this construct
shows that the folds of the ubiquitin repeats (bottom), ubiquitin carrier
(middle), and I27 guest (top) are preserved. (c) Fu histograms of the
construct modules (same order). Both histograms show that the carrier-
guest strategy does not alter the mechanical properties of the modules
involved. All distributions are normalized in b and c. The Gaussian fits to
the histograms are shown. (d) Typical force-extension recording of the
pFS-2þVAMP2 protein. VAMP2 shows no force peaks in SFMS (i.e., no
mechanical stability), thus the unfolding of the ubiquitin carrier is followed
by the peakless stretching of the guest VAMP2. The inset shows a represen-
tation of the ubiquitin carrier with the cytoplasmic region from VAMP2
(residues 1–94, top) hosted within it, visualized by VMD 1.8.6 (48).
FIGURE 3 pFS-2 protein. (a) Representation of the structure of ubiquitin
(left, PDB code 1D3Z) and the ubiquitinþMCS (right). The MCS is in-
serted into loop A-B of the ubiquitin structure (between residues T9 and
G10). It is composed of 14 amino acids and contains restriction sites for
the enzymes AgeI, BsiWI, SmaI, and MluI. The atomic structures were
visualized by VMD 1.8.6 (48). (b) Schematic representation of the pFS-2
protein. (c) Western blot to monitor the induction of the expression of the
pFS-2 protein cloned in the pRSETA vector (Stratagene) and using the
C41(DE3) E. coli strain (29). The nominal molecular mass of the protein
is 82 kDa according to ProtParam. The protein yield is very similar to
that obtained with pFS-1 (Fig. 2 b). (d) Purification of the recombinant
pFS-2 protein. As with the pFS-1 protein (Fig. 2 c), a single band is
observed in CB staining and in Western blots probed with each antibody.
(e) Typical force-extension recording of the pFS-2 containing (in this order)
the N2B region, the ubiquitin unfolding peaks (in black), and the ubiqui-
tinþMCS unfolding peak. This peak can readily be identified by its larger
DLc due to the insertion of the MCS into the ubiquitin cDNA sequence.
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demonstrate its potential (Fig. 4).MATERIALS AND METHODS
Design and construction of the pFS-1 vector
The pFS-1 vector was originally designed on the basis of a previously
described strategy (8). A human Ubi9 cDNA clone was used as a template
to PCR-clone the ubiquitin repeats (16). We used a fragment of the N2B
region from titin instead of its entire length for two reasons: first to reduce
the size of the final fusion protein, because proteins> 100 kDa typically are
poorly expressed in Escherichia coli (pET System Manual, Novagen,
Darmstadt, Germany), and second to avoid the formation of internal
disulfide bonds (24). The fragment of choice should not have any tertiarystructure, as it occurs for the full-length N2B (18). Based on the
predicted secondary structure of different candidate sequences of N2B
run at PROF (http://www.aber.ac.uk/~phiwww/prof/), we selected the frag-
ment of N2B from D145 to L349 (with both residues included).
With the exception of NotI, all of the restriction enzymes chosen
(BamHI, XbaI, SalI, SpeI, BssHII, XhoI, and KpnI, from the N- to
C-terminus; Fig. 2 a) leave cohesive ends encoding two amino acids (GS,
SR, VD, TS, AR, LE, and GT, respectively, in the one-letter code). NotI
requires the introduction of an extra nucleotide to avoid altering the reading
frame, and thus we introduced an extra adenosine (this restriction site with
this extension will code for AAA).
The cloning procedure to generate this vector was as follows: 1) The
first ubiquitin repeat was cloned in the plasmid pT7blue (Novagen) via
BamHI-XbaI. 2) The N2B fragment was inserted into the same vector afterBiophysical Journal 102(3) 682–690
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BamHI-Ubiq-N2B-SalI DNA fragment was cloned into pET24d (Novagen).
Then, as SalI and NotI are very close in this vector and digestion with
these enzymes could become problematic, we inserted synthetic oligonucle-
otides to separate these sites and facilitate digestion. These oligonucleotides
contained the sequences 50-GGCCGCCACTGAACCTGC-30 and 50- GGC
CGCAGGTTCAGTGGC-30 in such a way that upon hybridization, a
double-stranded oligonucleotide is formed with NotI cohesive ends and
phosphate groups at the 50-termini. Thus, we digested the pET24d plasmid
carrying BamHI-Ubiq-N2B-SalI with NotI and inserted the double-stranded
oligonucleotide. Then, the next ubiquitin repeat was cloned via SalI-NotI. 4)
The next ubiquitin repeat was first cloned into pT7blue via BamHI-NotI-
Ubiq-SpeI, and the fragment was then released via NotI-SpeI. The
BamHI-Ubiq-N2B-Ubiq-NotI fragment was also released from the
pET24d plasmid via BamHI-NotI, and both fragments were simultaneously
cloned into pT7blue via BamHI-SpeI. 5) The next cloning step involved the
ubiquitin repeat at the 30 position in the DNA sequence of the pFS-1
construct. The BamHI-XhoI-Ubiq-KpnI fragment was cloned into pT7blue
via BamHI-KpnI. 6) The plasmid was then digested with HindIII-XhoI and
the previous ubiquitin repeat in the pFS-1 vector was cloned here via
HindIII-BssHII-Ubiq-XhoI, obtaining the BssHII-Ubiq-Ubiq-KpnI
sequence cloned into pT7blue. 7) The resulting fragment was then released
using BssHII-KpnI and cloned simultaneously with the SpeI-Ubiq-BssHII
PCR fragment into pT7blue via SpeI-KpnI. 8) This sequence was then
released using SpeI-KpnI. Then, the BamHI-Ubiq-N2B-Ubiq-Ubiq-SpeI
sequence was also released from the pT7blue vector using BamHI-SpeI.
Both fragments were simultaneously cloned into pRSETA (Stratagene, La
Jolla, CA) or pQE80L (Qiagen, Duesseldorf, Germany) via BamHI-KpnI.Design and construction of the pFS-2 vector
We next modified the pFS-1 vector by inserting an MCS into a ubiquitin
repeat as a site for cloning the protein of interest according to the carrier-
guest strategy. To avoid affecting the fold of the carrier ubiquitin repeat,
the best candidate insertion sites were the loops that were naturally present.
Based on previous studies describing the modification of ubiquitin stability
by insertion of sequences in the different loops of its fold (25–27), we chose
to use the loop A-B (between residues T9-G10) because it showed the high-
est tolerance to insertions in terms of global fold, thermodynamic stability,
and loss of hydrogen bonds (Fig. 3 a). Also, we selected the ubiquitin repeat
at position 4 of the pFS-1 construct because it is placed in a central position
and therefore would allow us to gain the full benefit from the use of this
vector (Fig. 3 b).
For the restriction enzymes, we chose to use AgeI, BsiWI, SmaI, and
MluI, which code for the amino acids TG, RS, PG, and TR, respectively.
We also inserted two glycine residues at each terminus of the MCS to
make this region more flexible and to decrease the possibility of deleterious
effects on ubiquitin folding. Furthermore, we inserted a spacer between the
restriction sites to improve the efficiency of the enzymatic digestion in this
MCS (TCATCA, which codes for SS). The complete sequence of the MCS
was CTCACTGGTGGAACCGGTCGTACGTCATCACCCGGGACGC
GTGGAGGAGGC (nucleotides that belong to the ubiquitin repeat are
shown in italics, and those that form the sites of the restriction enzymes
described above are shown in bold).
The cloning process was as follows: the SpeI-Ubiq-BssHII DNA fragment
was first cloned into the pCR2.1 vector (Invitrogen, San Diego, CA). Then,
using the QuickChange kit (Stratagene), we inserted the MCS sequence in
two steps: first the GGTGGAACCGGTCGTACGTCA sequence and then
the TCACCCGGGACGCGTGGAGGA sequence. Finally, we cloned the
SpeI-UbiqþMCS-BssHII DNA fragment into the pFS-1 via SpeI-BssHII.Cloning guest proteins into pFS-2
To clone the I27 module inside the MCS (pFS-2þI27), we selected BsiWI
and MluI sites. Therefore, the GGTGRS and TRGG amino acid sequencesBiophysical Journal 102(3) 682–690of the MCS remained in the N- and C-termini of the I27 module, respec-
tively (Fig. 4 a). For PCR amplification we used as a template a plasmid
containing 12 repeats of the I27 module (1). The cytoplasmic region (resi-
dues 1–94) of VAMP2 from Rattus norvegicus was cloned into AgeI-SmaI
restriction sites (pFS-2þVAMP2), leaving the amino acids GGTG and
PGTRGG of theMCS on either side of VAMP2.We used a plasmid contain-
ing the entire VAMP2 sequence (pGEX-KGVAMP2 (28)) as a template for
PCR amplification.
In all of these cloning steps, we used the XL1-Blue E. coli strain
(Stratagene). We verified all of the sequences by sequencing both strands
of the DNA.Expression and purification of the pFS-1
and pFS-2 proteins
To optimize the production of pFS-1 and pFS-2 recombinant proteins, we
tested a battery of E. coli strains for induction and yield as well as for mini-
mizing degradation of the recombinant protein. Specifically, we tested the
C41 (DE3) (29), BL21star (DE3) (Invitrogen), and M15[pREP4] (Qiagen)
strains with the pFS-1 and pFS-2 constructs inserted into either the pRSETA
or pQE80L vectors. Cells were grown at 37C shaking at 300 rpm until an
OD595 of 0.5–0.8 was reached, and expression was induced by addition of
1 mM of isopropyl b-D-thiogalactopyranoside (IPTG) for 4 h. We found
that the best combination was that of the pRSETA plasmid and the
C41(DE3) strain (Figs. 2 b and 3 c) (29).
Bacterial cells were lysed by treatment with 1 mg/ml lysozyme and 1%
Triton X-100 (30). We purified the recombinant proteins by Ni2þ-affinity
chromatography using Histrap HP FPLC columns (GE Healthcare,
Uppsala, Sweden) on an FPLC apparatus (A¨KTA Purifier, GE Healthcare)
using 50 mM sodium phosphate buffer/500 mMNaCl (pH 7.4) with 50 mM
and 500 mM imidazole in the binding and elution buffers, respectively.
The purified fractions were concentrated and the buffer exchanged to phos-
phate buffer saline (PBS)/5 mM DTT by ultrafiltration using Amicon 10K
filters (Millipore; Billerica, MA). After a brief sonication pulse, we further
purified the sample by Strep-tag affinity purification using Streptrap HP
FPLC columns (GE Healthcare). The binding buffer was PBS and the
elution buffer was PBS/2.5 mM desthiobiotin. For pFS-2þVAMP2, after
the Ni2þ-affinity chromatography purification step, the sample was further
purified by size exclusion chromatography using a HiLoad 16/60 Superdex
TM 200 column (GE Healthcare) with 100 mM TrisHCl buffer (pH 7.0)
containing 1.25 M guanidinium chloride (this concentration does not dena-
ture the ubiquitin repeat and it allows the contaminants that coelute with the
protein to be removed) (31). The purified fractions were concentrated again
and the buffer was exchanged to PBS/5 mM DTT/0.2 mM EDTA (pH 7.4;
for pFS-1 and pFS-2þI27) or TrisHCl 10 mM/5 mM DTT (pH 7.5; for
pFS-2þVAMP2) by ultrafiltration using Amicon 10K filters (Millipore).
Although the yield of pure recombinant protein was not very high (~1 mg
pure protein per liter of bacterial culture), it was very pure (>95%). Thus,
a single band was observed in Coomassie Blue (CB)-stained gels, as well as
in Western blots probed with antibodies against the two purification tags
present in the pFS-1/pFS-2 proteins (Figs. 2 c and 3 d).AFM-SMFS of the pFS-1 and pFS-2 proteins
The AFM we used is a slightly modified version of a previously described
in-house-made AFM (32) with added imaging capabilities (33). We deter-
mined the spring constant of each Si3N4 cantilever (MLCT-AUNM; Veeco
Metrology Group, Santa Barbara, CA; and BioLever, Olympus, Tokyo,
Japan) using the equipartition theorem (34), and found that it ranged
from 35 to 70 pN/nm for MLCT-AUNM and ~30 pN/nm for Biolever canti-
levers. The noise calculated for the cantilevers was ~6 pN (13). All exper-
iments were performed in the so-called length-clamp mode of the AFM (1)
at a constant pulling speed of 0.4 nm/ms. The elasticity of the stretched
proteins was analyzed fitting the force curves to the WLC model (3,35):












where F is the force, p is the persistence length, x is the end-to-end length,
and Lc is the contour length of the stretched protein. Lc and p are the adjust-
able parameters.
We used two different types of AFM substrates to test the efficiency of
pulling. The pFS vectors can be covalently attached to gold-coated cover-
slips through the cysteine residues located at the C-terminus (20), or to
Ni2þ-NTA functionalized glass coverslips through the His-tag present
at the N-terminus (19). A drop of pure protein preparation (~2–8 ml,
~0.2–0.5 mg/ml) was applied on top of a drop of the corresponding buffer
deposited onto the substrate and allowed to adsorb for ~10 min. These
methods were described previously (1,12,13,36), and the efficiency of pull-
ing in both substrates was comparable and the results obtained were
identical.
To validate pFS-1, we only selected recordings that showed the spacer
region of 50–80 nm (~80 nm if the protein is being pulled from its
termini), resulting from the stretching of the N2B fragment, followed
by no more than six force peaks from the mechanical unfolding of the
ubiquitin repeats (Fig. 2 d). For the carrier-guest strategy using hosted
proteins, apart from the spacer region and several force peaks that
originate from the unfolding of the ubiquitin repeats, the recordings
should always show the force peak that originates from the unfolding
of the carrier ubiquitin repeat (easily identified by its larger DLc value;
Fig. 3 e) before the stretching of the guest protein (Fig. 4, a and d)
(23,36,37).
All of the data reported here were analyzed with the use of Igor Pro 6.0
(Wavemetrics, Lake Oswego, OR) and are expressed as the mean value5
standard deviation.RESULTS AND DISCUSSION
pFS series of expression vectors
The pFS-1 is a cloning/expression vector that encodes for
a fusion heteropolyprotein that facilitates the analysis of
any protein of interest (but particularly for structured pro-
teins) by AFM-SMFS. It is formed by several human ubiq-
uitin repeats (UniProtKB/Swiss-Prot code P0CG47) and
a fragment of the N2B protein from human cardiac titin
(UniProtKB/Swiss-Prot code Q8WZ42). The former serves
as a single-molecule marker, and the latter serves as a spacer
that situates the force events of the polyprotein and those of
the protein of interest at a distance from the proximal region
of the force-extension recordings, which is usually contam-
inated (Figs. 1 and 2). This vector also contains a variety of
restriction sites between the repeats that facilitate the
cloning of any protein of interest into it (Fig. 2 a). Further-
more, it contains two terminal tags (one at each terminus)
to optimize the purification of the full-length form of the
recombinant protein. In a second version of the vector,
pFS-2, one ubiquitin unit contains an MCS in a tolerant
force-hidden loop into which proteins with low and/or
complex/polymorphic mechanostability (e.g., some IDPs)
can be cloned. This strategy protects the protein of interest
behind the mechanical clamp of the ubiquitin carrier,
facilitating the selection of unambiguous force recordings
(Figs. 3 and 4).Nanomechanics of pFS vectors
We performed AFM-SMFS on the purified pFS-1 and pFS-2
proteins to show their full potential (Figs. 2 d, 3 e, and 4).
The N2B fragment was seen to behave as a random coil
IDP, as does the full-length protein (18). It contains 204
amino acids, which upon stretching from its termini should
display an extension of ~81 nm (nominal extension, consid-
ering a gain in contour length of 0.4 nm per stretched amino
acid) (4). Any force peak that appeared in this region was
discarded from our analyses. Ubiquitin repeats showed an
Fu of 1895 37 pN and a DLc of 23.45 0.5 nm (n ¼ 574;
Fig. 4, b and c), which are, in principle, comparable to
those previously reported (16). The slightly lower Fu values
observed here may reflect the influence of the different linker
sequences that flank ubiquitin in the pFS vectors (which are
close to the mechanical clamp of the ubiquitin repeats and
may therefore slightly affect their mechanical stability by
steric/electrostatic effects) or possible unspecific interactions
between modules in the polyprotein. These effects have
been observed in other proteins (12,38–40). The ubiquitin
repeat carrying the MCS in pFS-2 had an Fu of 185 5
41 pN and a DLc of 28.35 0.6 nm (n¼ 55), indicating that-
the mechanical stability of this module is not affected by
insertion of the MCS. The gain in contour length of ~5 nm
is the result of the extra residues added by theMCS (14 amino
acids  0.4 nm/amino acidz 5 nm (4)).
It should be noted that, in principle, the presence of a
relatively long elastic linker in the fusion heteropolyprotein
may alter the mechanostability of the protein under study
(41). However, this effect is estimated to be a mere increase
of 0.1–0.2 pN/nm (42). In our setup and experimental con-
ditions, using I27 polyproteins (1), we estimated that this
effect would result in an increase of 10 pN every 100 nm
of extension (J. Oroz and M. Carrio´n-Va´zquez, data not
shown). Hence, the stretching of the N2B fragment present
in the pFS vectors would result in an increase of 8–16 pN
in the Fu of the protein under study, a force value that is
roughly within the error range of the measurements. Thus,
this effect can be considered negligible for most purposes.
Nanomechanics of a structured protein grafted
in pFS-2: titin I27 module
To validate the carrier-guest strategy, we first used a protein
module with a defined structure and well-known mechan-
ical properties, the I27 module from human cardiac titin
(UniProtKB/Swiss-Prot code Q8WZ42 (1)). As expected
from our design, the carrier ubiquitin repeat of the resulting
fusion protein (termed pFS-2þI27) unfolded before the
force-protected I27 module did (Fig. 4 a) (23). This I27
module grafted within the ubiquitin carrier had an Fu of
203 5 20 pN and a DLc of 27.2 5 0.4 nm (n ¼ 13;
Fig. 4, b and c), in close agreement with previously reported
values (1). Likewise, the carrier ubiquitin repeat had an Fu
of 179 5 46 pN and a DLc of 30.0 5 0.9 nm (n ¼ 13).Biophysical Journal 102(3) 682–690
688 Oroz et al.This increase in DLc of ~7 nm compared with a regular
ubiquitin corresponds to the length of the remaining MCS
(10 residues ¼ 4 nm) (4) and the folded I27 included inside
this carrier ubiquitin (the size of folded I27 is 3–4 nm (1)).
Hence, the mechanical stability of both modules did not
appear to be modified in the carrier-guest construct, demon-
strating that the ubiquitin carrier can be used to graft
folded proteins inside its fold with virtually no change in
the mechanostabilities of both proteins. However, there
appear to be limitations in the loading capabilities of the
carrier that may compromise its mechanostability (J. Oroz
and M. Carrio´n-Va´zquez, unpublished results). In fact, as re-
ported previously, the grafting of proteins with distant
N-/C-termini may affect the fold of the carrier protein and
lead to the mutual exclusiveness of the folding between
the carrier and guest proteins (37,43,44). A possible solution
for this negative effect would be to include long flexible
linkers between both modules to reduce the steric effects
that impede their folding (44). Indeed, our results showing
the preserved fold for the carrier ubiquitin and the guest
I27 (with distant N-/C-termini) in the pFS-2þI27 were
somewhat surprising considering previous work (37). This
unexpected success may be due to the inclusion of several
glycine residues (44) in the MCS of the carrier ubiquitin.
In the future, the extension of this glycine region may avoid
possible problems with larger proteins.Nanomechanics of a nonfibrillogenic IDP grafted
in pFS-2: VAMP2
We next tested whether the carrier-guest strategy was
suitable for carrying out an unambiguous nanomechanical
analysis of IDPs. Accordingly, we cloned the cytoplasmic
region (amino acids 1–94) of VAMP2 (a.k.a. synaptobrevin)
from R. norvegicus (UniProtKB/Swiss-Prot code P63045),
a component of the SNARE complex (45), within the carrierpFS-1 (left panel shows its mechanical representation) is sufficient for protei
with complex or polymorphic patterns of force peaks, the force peak of the ‘‘carr
serves to announce the latter appearance of the events of the protein of interest (
proximal region). Thus, using the carrier-guest strategy, the mechanical determin
force-hidden behind the mechanical clamp of the carrier, so that the protein und
after) the carrier protein, and thus will be at a distance from the noisy proximal re
in the force-extension recordings because it has a larger DLc value (>DLc in th
a standard heteropolyprotein strategy, the features from the protein of interest c
Biophysical Journal 102(3) 682–690ubiquitin repeat. This nonfibrillogenic IDP was expected to
behave as a random coil and thus shows no force peaks
when stretched at the usual pulling velocity (18). As ex-
pected (23,37), the force-extension recordings had a force
peak originated from themechanical unfolding of the ubiqui-
tin carrier, followed by the stretching of the guest VAMP2
with no mechanical resistance other than entropic elasticity.
The DLc value obtained was 63 nm, which corresponds to
the length of the unfolded carrier ubiquitin repeat plus that
of synaptobrevin (~26 nm from this carrier ubiquitin, as four
residues from its MCS were removed for VAMP2 cloning,
and ~37 nm from the stretching of VAMP2; Fig. 4 d) (4).
Moreover, the carrier ubiquitin repeat again displayed a
mechanical behavior comparable to that of regular ubiquitin.
An alternative version of the pFS-2 in which titin I27
was used as a carrier module instead of ubiquitin, pFS-2/
I27, was also used to host VAMP2 (cloned in an MCS
formed by AgeI and SmaI restriction sites, located between
residues A42 and A43 in the CD loop of I27), and gave
comparable results (22). Although the FG loop is quite vari-
able in length among titin Ig modules, and was successfully
used to insert glycine residues (46), in practice the CD
loop seemed to tolerate insertions better (H. Li and J. M.
Ferna´ndez, Columbia University, personal communication,
2002).CONCLUSION
The standard heteropolyprotein strategy that has been used
to date for AFM-SMFS relies on the use of several repeats
of a marker protein arranged in series, such that the unfold-
ing of a protein with lower mechanostability than the marker
occurs at the beginning of the force-extension recordings
(Figs. 1–5). However, this strategy has severe drawbacks
for analyzing low-mechanical stability proteins or IDPs by
AFM-SMFS (Fig. 1) (11).FIGURE 5 Advantages of the pFS family of
vectors for AFM-SMFS: the spacer and the carrier
guest strategies. When the protein of interest has
a lower mechanical stability (small ring, top) than
the single-molecule marker (larger rings, black),
the use of the standard heteropolyprotein strategy,
with the mechanical clamps of the protein marker
arranged in series, often results in data contami-
nated with spurious force peaks that originate
from nonspecific sources in the noisy region of
the recordings (proximal to substrate). The use of
the N2B region allows the data from the protein
of interest to appear away from this region. The
ns with unique or simple patterns of force peaks. In the case of proteins
ier’’ (larger ring) in the pFS-2 (cartoon shows its mechanical representation)
combined with the N2B strategy allows the carrier to appear away from the
ants of the protein under study (small ring connected to the larger ring) are
er study will always be stretched after (though not necessarily immediately
gion of the recording. The ubiquitin carrier protein can readily be identified
e figure) than that of a regular ubiquitin repeat (black). Note that by using
an appear in the noisy region.
Unequivocal Protein Nanomechanics 689We developed a family of cloning/expression vectors
(pFS) for general use in AFM-SMFS (Figs. 2, 3, and 5).
The expression of any protein in this vector produces a fusion
heteropolyprotein that can be unequivocally analyzed by
AFM-SMFS. Furthermore, the expression and purification
protocols are optimized such that very pure preparations
of the full-length protein can be easily obtained. This
vector contains several elements that make this robust and
powerful approach the system of choice for typical AFM-
SMFS applications. pFS-2 provides a new, to our knowledge,
strategy (the carrier-guest approach) that is extremely useful
for the unequivocal nanomechanical analysis of proteins
with low mechanical stability, and particularly for proteins
with complex/polymorphic mechanostability, such as fibril-
logenic IDPs (Fig. 4) (22).
We also present a proof-of-concept to demonstrate the
advantages of using these new vectors and the carrier-
guest strategy to unambiguously analyze low-mechanical-
stability proteins and IDPs (Figs. 4 and 5) (12,23). The
importance of AFM-SMFS for studying IDPs is highlighted
by the causal role played by amyloidogenic IDPs in several
diseases (21). Here, we analyzed an IDP, the VAMP2 protein
(45), that is not fibrillogenic or related to any amyloidogenic
disease. This protein is assumed to be a random coil, and
accordingly it offered no mechanical resistance in AFM-
SMFS. Of more importance, the use of the pFS-2 vector
also allows the unambiguous mechanical analysis of fibrillo-
genic IDPs, specifically those that are known to be causally
related to neurodegenerative diseases (i.e., neurotoxic
proteins) and to adopt different conformations (47). This
analysis revealed that these proteins display a broad
mechanical polymorphism, ranging from abundant low-me-
chanostability conformers to low-abundance conformers
with very high mechanostability (22). Of interest, the
unequivocal characterization of the conformational poly-
morphism and the discovery of hypermechanostable
conformers in those proteins could only be achieved by
means of the carrier-guest strategy described here. However,
and particularly when analyzing the nanomechanics of
proteins with a tendency to oligomerize (e.g., neurotoxic
proteins), the strategy presented here only guarantees the
stretching of single molecules. The analyzed molecule
could still be involved in a series of interactions (with the
AFM elements, substrate or cantilever tip, and other sur-
rounding IDP molecules forming oligomers). To discard
this possibility, one should employ additional controls,
such as using inhibitors of the oligomerization process
(22) or performing refolding experiments in buffer that is
devoid of IDPs.
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